Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun;72(3):597-603.
doi: 10.1007/s12020-021-02749-3. Epub 2021 May 17.

Vitamin D in the Covid-19 era: a review with recommendations from a G.I.O.S.E.G. expert panel

Fabio Massimo Ulivieri  1 , Giuseppe Banfi  2   3 , Valentina Camozzi  4 , Annamaria Colao  5 , Anna Maria Formenti  6 , Stefano Frara  6 , Giovanni Lombardi  7   8 , Nicola Napoli  9 , Andrea Giustina  6
Affiliations
Review

Vitamin D in the Covid-19 era: a review with recommendations from a G.I.O.S.E.G. expert panel

Fabio Massimo Ulivieri et al. Endocrine. 2021 Jun.

Abstract

Vitamin D (VITD) is a key hormone for bone health and has relevant extra-skeletal effects that might play a role in the prevention and treatment of COronaVIrus Disease 19 (COVID-19). Literature regarding this scenario is voluminous but controversial. Glucocorticoid Induced Osteoporosis Skeletal Endocrinology Group (G.I.O.S.E.G) has been present in the scientific debate about the use of VITD and has regularly interfaced national regulatory agencies to ensure appropriateness of its employment. Given the current pandemic and the questions on COVID-19 and VITD, G.I.O.S.E.G. appointed an expert panel to advise how to consider this issue best. The results of these deliberations are reported in the current recommendation paper.

Keywords: COVID-19; G.I.O.S.E.G.; Pandemic; Sars-Cov-2; VITD; Vitamin D.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Bouillon R, Marcocci C, Carmeliet G, Bikle D, White JH, Dawson-Hughes B, Lips P, Munns CF, Lazaretti-Castro M, Giustina A, Bilezikian J. Endocr. Rev. 2019;40:1109. doi: 10.1210/er.2018-00126. - DOI - PMC - PubMed
    1. A. Giustina, R.A. Adler, N. Binkley, J. Bollerslev, R. Bouillon, B. Dawson-Hughes, P.R. Ebeling, D. Feldman, A.M. Formenti, M. Lazaretti-Castro, C. Marcocci, R. Rizzoli, C.T. Sempos, and J.P. Bilezikian, in Rev. Endocr. Metab. Disord. (Springer, 2020), pp. 89–116 - PMC - PubMed
    1. D. N.1533/2019, Gazz. Uff. Della Repubb. Ital. https://www.aifa.gov.it/documents/20142/1030827/Determina_n.1533_2019_No... (2019)
    1. Giustina A, Adler RA, Binkley N, Bouillon R, Ebeling PR, Lazaretti-Castro M, Marcocci C, Rizzoli R, Sempos CT, Bilezikian JP. J. Clin. Endocrinol. Metab. 2018;104:234. doi: 10.1210/jc.2018-01414. - DOI - PubMed
    1. A. Giustina, R. Bouillon, N. Binkley, C. Sempos, R.A. Adler, J. Bollerslev, B. Dawson-Hughes, P.R. Ebeling, D. Feldman, A. Heijboer, G. Jones, C.S. Kovacs, M. Lazaretti-Castro, P. Lips, C. Marcocci, S. Minisola, N. Napoli, R. Rizzoli, R. Scragg, J.H. White, A.M. Formenti, and J.P. Bilezikian, JBMR Plus 4, (2020)